Daniel P Gitterman
Overview
Explore the profile of Daniel P Gitterman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
81
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gitterman D, Hay Jr W, Langford W
Pediatr Res
. 2023 Jan;
PMID: 36631692
Despite the significant increase in pediatric funding, an important question is whether recent changes in the burden of disease and conditions (child and adolescent mortality and nonfatal health loss) are...
2.
Gitterman D, Hay Jr W, Langford W
Pediatr Res
. 2022 Jul;
93(4):797-800.
PMID: 35817956
There is unmistakable evidence of increased NIH funding for pediatric and perinatal research, but there is much work to be done. To further promote NIH-funded pediatric and perinatal research, we...
3.
Malik T, Gitterman D, Lavin D, Lomax-Browne H, Hiemeyer E, Moran L, et al.
Proc Natl Acad Sci U S A
. 2021 Mar;
118(13).
PMID: 33753502
Genetic variation within the factor H-related (FHR) genes is associated with the complement-mediated kidney disease, C3 glomerulopathy (C3G). There is no definitive treatment for C3G, and a significant proportion of...
4.
Gitterman D, Langford W, Hay Jr W
Pediatr Res
. 2018 Jul;
84(3):328-332.
PMID: 29976967
Background: The amount of federal dollars allocated to improving the health of our pediatric population can serve as an indicator of the priority placed on child well-being. Although Congress has...
5.
Gitterman D, Langford W, Hay Jr W
JAMA Pediatr
. 2018 Jan;
172(3):287-293.
PMID: 29340575
In this article, we examine the status of the National Institutes of Health (NIH) pediatric research portfolio between start of federal fiscal year (FY) 1992 and end of FY 2015....
6.
Sheridan S, Draeger L, Pignone M, Sloane P, Samuel-Hodge C, Finkelstein E, et al.
Contemp Clin Trials
. 2013 Aug;
36(2):394-405.
PMID: 23916919
Background: Although lifestyle and medications are effective for coronary heart disease (CHD) risk reduction, few studies have examined the comparative effectiveness of various strategies for delivering high quality CHD risk...
7.
Gitterman D, Scott J
J Health Polit Policy Law
. 2011 Jun;
36(3):555-63.
PMID: 21673263
No abstract available.
8.
Hay Jr W, Gitterman D, Williams D, Dover G, Sectish T, Schleiss M
Pediatrics
. 2010 May;
125(6):1259-65.
PMID: 20457684
Although pediatric research enjoyed significant benefits during the National Institutes of Health (NIH) doubling era, the proportion of the NIH budget devoted to the pediatric-research portfolio has declined overall. In...
9.
Gitterman D, Hay Jr W
Pediatr Res
. 2008 Sep;
64(5):462-9.
PMID: 18787420
This review article examines the National Institutes of Health's (NIH) overall budget and its pediatric research funding across three time periods: predoubling [fiscal year (FY) 1992-1997]; doubling (FY 1998-2003); and...
10.
Gitterman D, Greenwood R, Kocis K, Mayes B, McKethan A
Health Aff (Millwood)
. 2004 Sep;
23(5):113-24.
PMID: 15371375
This paper examines National Institutes of Health (NIH) pediatric research spending in absolute terms and relative to the doubling of the NIH overall budget between fiscal years 1998 and 2003....